Regarding the PD-L2 ligand, its expression in TCs was detected in 79% (38/48) of the tumor samples (Figure 3b), and in intratumoral (Figure 3d) and stromal (Figure 3f) TILs of all analyzed samples (100%; 48/48). This evidence concerns the gene PDCD1LG2 and neoplasm.